Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial

DSpace Repository

Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial

Author: Einsele, Hermann; Engelhardt, Monika; Tapprich, Christoph; Mueller, Juergen; Liebisch, Peter; Langer, Christian; Kropff, Martin; Muegge, Lars O.; Jung, Wolfram; Wolf, Hans-Heinrich; Metzner, Bernd; Hart, Christina; Gramatzki, Martin; Hertenstein, Bernd; Pfreundschuh, Michael; Roesler, Wolf; Fischer, Thomas; Maschmeyer, Georg; Kanz, Lothar; Hess, Georg; Jaeger, Elke; Bentz, Martin; Duerk, Heinz A.; Salwender, Hans; Hebart, Holger; Straka, Christian; Knop, Stefan
Tübinger Autor(en):
Kanz, Lothar
Published in: British Journal of Haematology (2017), Bd. 179, H. 4, S. 586-597
Verlagsangabe: Wiley
Language: English
Full text: http://dx.doi.org/10.1111/bjh.14920
ISSN: 1365-2141
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)